Investors & Media
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. To learn more about The Medicines Company and our work driving innovation in the cardiovascular disease space, visit our media toolkit here.
Press Releases
04 Oct 2019The Medicines Company to Participate in the Chardan 3rd Annual Genetic Medicines Conference25 Sep 2019The Medicines Company Announces Positive Topline Results for ORION-10 Phase 3 Study of Inclisiran in ASCVD Patients25 Sep 2019The Medicines Company Announces Positive Topline Results for ORION-9 Phase 3 Study of Inclisiran in Heterozygous Familial Hypercholesterolemia Patients
View AllEvents & Presentations
Upcoming Events
There are no upcoming events at this time. Please check back.
Recent Events
Date
Event Details